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IMPAIRED PHAGOCYTOSIS IN PERITONITIS 
EXUDATE SECONDARY TO COMPLEMENT 
CONSUMPTION* 
A . B I L L I N G , * 1 D . F R Ö H L I C H , ' M A R I A N N E J O C H U M , 2 H . K O R T M A N N 1 
1 C h i r u r g i s c h e K l i n i k und P o l i k l i n i k der Universität München, K l i n i k u m Großhadern; 
2 I n s t i t u t für klinische Chemie und klinische Biochemie der Universität München, 
West Germany 
(Accepted for publication 1 1 J a n u a r y , 1 9 8 8 ) 
Peritonitis exudates contain numerous viable bacteria despite an intense inflammatory reaction with ingress 
of a large number of intact, activated phagocytes. Recognition and labelling of foreign particles (opsoniza-
tion) is an essential prerequisite for efficient phagocytosis. An investigation of Opsonin levels and opsonic 
activity in Peritonitis exudates and serum from patients with Peritonitis was carried out. Serum opsonic 
activity was well correlated with levels of the Opsonins, IgG and C3 complement. In Peritonitis exudates 
Opsonin concentrations were moderately reduced but opsonic activity was almost abolished. Crossed 
immunoelectrophoresis revealed a pronounced breakdown of C3 complement into smaller fragments. 
These exudates contained a large number and wide variety of pathogenic bacteria, as well as many 
phagocytes. In purulent exudates, we found very high concentrations of granulocytes, lysosomal and 
oxidative enzymes, and free proteolytic activity. It is concluded that specific Opsonin consumption and 
nonspecific cleavage can contribute to the detected C3 breakdown. Local treatment of impaired opsoniza-
tion by Substitution of intact Opsonins and protease inhibitors should be considered. 
K E Y WORDS: Peritonitis, phagocytosis, opsonization, granulocyte enzymes, protease inhibitors. 
I N T R O D U C T I O N 
Purulent Peritonitis exudates are characterized by local survival of bacteria despite the 
presence of large numbers of polymorphonuclear leukocytes ( P M N L s ) . So far, there 
is no satisfactory explanation for this paradoxical Situation. It is generally accepted 
that complement, antibodies and P M N L s are the essential components in host 
defence against bacterial infection.1 Phagocyte function, the main cellular component 
of the System, seems to be intact in Peritonitis exudates.2 , 3 
The humoral immune process of recognizing and labelling a microbe as antigenic-
ally foreign (opsonization) is a prerequisite for sufficient phagocytosis. Opsonization 
is mainly achieved by the phagocytosis promoting factors, IgG and C3 complement. 4 , 5 
Thereby complement is activated, resulting in the enhanced liberation of Opsonins, 
other mediators of inflammation and bacteriolytic substances (Figure 1). 
Physiological C3 activation eventually results in its breakdown into the fragments, 
C3c and C3d. Nonspecific proteolytic degradation of Opsonins in abscesses and 
:Presented at the International Congress on Intraabdominal Infections, Hamburg, F R G , June 1987. 
*Correspondence to: Dr. med. Arend Billing, Chirurgische Klinik und Poliklinik der Universität Mün-
chen, Klinikum Gro/madern, Marchionistr. 15, 8000 München 70, Germany (FRG). 
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F I G U R E 1 
acc. to30). 
The complement System with its key Factor C3 playing a central role in inflammation (modif. 
empyema has also been deseribed.6,7 These Opsonin split products can retain their 
antigenicity, accounting for high Opsonin levels by immunological determination 
despite the absence of opsonic function. Therefore, both Opsonin levels and their 
activity must be considered in evaluating opsonization. 
Düring phagocytosis P M N L lysosomal enzymes are liberated into the phagosome. 
However, the process is also accompanied by a major extracellular enzyme release.8 
In sepsis, endogenous Proteinase inhibitors can be impaired by oxidative enzymes or 
oxygen-derived free radicals.9 Extensive P M N L elastase release in an area of in-
flammation can overwhelm local inhibitor activity, leading to free proteolytic enzyme 
activity. Extensive knowledge has accumulated in recent years regarding opsonization 
and P M N L function in the blood of septic patients. Little, however, is known about 
intraabdominal fluid levels of complement and Immunoglobulins,10,11 and no data are 
available about Opsonin integrity and opsonic function in Peritonitis exudates. 
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Recently, we found evidence for a marked intraabdominal opsonic dysfunction in 
Peritonitis.3 Modified chemiluminescence assays provide a quantitative method for 
rapid determination of opsonic activity in blood. 1 2 , 1 3 Consequently, we developed a 
similar System to evaluate opsonic function in exudates. Integrity of C3 was inves-
tigated by immunoelectrophoresis. The aim of our study was to elucidate the path-
ophysiology of opsonization in Peritonitis exudates. We examined patients with acute 
and persistent Peritonitis. The latter group was treated with Etappenlavage,1 4 that is, 
scheduled abdominal lavage until clearance of the abdominal cavity. 
M A T E R I A L S A N D M E T H O D S 
Sampling Procedure 
Düring 24 Operations for acute diffuse purulent Peritonitis and 22 Operations under 
Etappenlavage, exudate and blood samples were drawn simultaneously. Exudates 
collected with disposable plastic syringes were cleared of cells and debris by immediate 
centrifugation. Blood samples were processed to provide serum and E D T A plasma. 
Chemiluminescence Assay for Opsonic Activity 
Opsonic activity was determined using a chemiluminescence assay.15 Briefly, zymosan 
was preopsonized by incubation with normal serum, patients' serum or patients' 
exudate for 15 min at 37°C. The final assay Solution contained 0.05 ml diluted E D T A 
blood (1:15 in phosphate buffered saline (PBS)), 0.8 ml Veronal buffer and 0.1 ml 
Luminol Solution (0.7 m M ) , resulting in a final blood dilution of 1:300. The assay was 
started by adding 0.05 ml of preopsonized Zymosan (20 mg/ml). Chemiluminescence 
was measured using a Biolumat (Fa. Berthold, Wildbad, F R G ) and integrated over 
30 min using a microcomputer (Apple He). Opsonic activity of patient serum or 
exudate was expressed as a percentage of the value obtained using normal serum. 
I m m u n o l o g i c a l evaluation of Opsonins and related products 
Immunological C3 and IgG levels were measured with a Standard radial immunodif-
fusion assay (Behringwerke, Marburg, F R G ; normal values = 100%: C3 82 mg/dl 
and IgG 1250 mg/dl). C3 split products were demonstrated by crossed immunoelec-
trophoresis according to Ganroth 1 6 employing the same C3c antibody as used in the 
radial immunodiffusion. C3a was determined by radioimmunoassay available from 
Upjohn. 1 7 
Tests for P M N L - e n z y m e s 
Elastase18 in complex with <x, -proteinase inhibitor (a, PI) and myeloperoxidase1 9 
concentrations were measured by E L I S A (test kits from E. Merck, Darmstadt, F R G ) . 
The reference ränge for plasma elastase is 50-181 /ig/1, and that for myeloperoxidase 
25-47 jug/1. Free elastase activity was measured with a chromogenic peptide Sub-
strate20 or by adding a surplus of a, PI and then reassaying the sample for elastase-a, 
PI complex. 
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M i c r o b i o l o g i c a l Investigations 
Aerobic and anaerobic bacterial cultures were prepared from all exudates immedi-
ately after sampling. 
Other Assays 
Protein content was determined by the Biuret method. 2 1 Serum and exudate electro-
phoresis was performed according to Grabner et al.22 W B C was carried out in a 
Neubauer Chamber after staining with Türks 's Solution (from E. Merck, Darmstadt, 
F R G ) . a, -PI was measured with a Standard radial immunodiffusion assay (Behring-
werke, Marburg; normal ränge: 190-350 mg/1). 
Statistics 
Computerized correlation analysis was performed for Opsonin concentration and 
opsonic activity selecting the most appropriate correlation out of degree of regression 
1 to 4. 
R E S U L T S 
In normal serum, there was a close correlation between Opsonin levels and opsonic 
activity and only small amounts of C3 activation products (Table 1). Normal serum 
dilution results in an S-shaped relationship between opsonic activity and a C3/IgG 
index. The latter is a simple addition of C3 and IgG concentrations (Figure 2). In 
acute Peritonitis, serum Opsonin levels, opsonic activity and protein content were 
considerably diminished and lay close to the lower limit of the normal ränge. The C3a 
level in these samples, however, was 5.3 fold increased. In patients with persistent 
Peritonitis, IgG levels were normal, resulting in a normal opsonic activity despite 
continuous C3 activation. The relationship between opsonic levels and opsonic 
activity in the patients' sera was very close to that of normal serum. Computerized 
Statistical analysis for patients' serum values shows a best correlation in the third 
degree of regression with the variables y = \0~5-x3 - 0.006-x2 + 1.42-x - 14.7 
which results in a S-shaped curve, very similar to that of normal serum dilution 
(Figure 2). Compared to normal, serum Opsonins in patients' sera are intact and there 
is no deficit in Opsonin function. 
Opsonic activity was investigated in three types of Peritonitis exudate: 
T A B L E I 
Serum factors contributing to opsonic activity (OA) (mean ± SEM) 
normal serum acute Peritonitis, persistent Peritonitis, 
(n = 20) serum (n = 30) serum (n = 30) 
protein content 7.08 ± 0.7 5.1 ± 0.1 5.5 ± 0.12 
(g/dl) 
IgG (mg/dl) 1128 + 31 800 ± 49 1260 + 92 
C3 (mg/dl) 79.9 + 2.3 62.3 + 3.86 59.0 ± 3.1 
C3a O'g/dl) 12.8 + 1.24 67.7 + 10.4 67.3 + 8.0 
O A (% of normal) 96.0 + 5.7 84.5 ± 6.1 93.0 + 5.4 
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F I G U R E 2 Correlation of opsonic activity and Opsonin concentration in serum. The C3-IgG-index 
results from addition of both serum concentrations (in % of normal). The curves represent the relationship 
obtained by diluting normal serum and in undiluted patients' serum. The points represent patients with 
acute and persistent Peritonitis. 
(a) exudates found in the first Operation for acute Peritonitis; 
(b) purulent exudates from patients with persistent Peritonitis; 
(c) clear exudates found at the successful end of Etappenlavage (EL) . 
The results are summarized in Table II. Mean exudate protein content was lowest in 
T A B L E II 
Opsonization-related factors and opsonic activity (OA) in Peritonitis exudates (mean + SEM). O A e x p is the 
expected OA according to the correlation between IgG/C3 (concentrations of IgG + C3) and O A in 
serum, O A r e a ) is the actual O A in acute Peritonitis and Etappenlavage (EL) exudates 
acute Peritonitis purulent E L clear El 
exudate (n = 30) exudate (n = 30) exudate (n = 15) 
protein content 3.25 ± 0.23 3.5 ± 0.13 4.1 ± 0.28 
Cg/dl) 
IgG (mg/dl) 470 + 43 690 + 62 630 ± 70 
C3 (mg/dl) 28 ± 2.7 21 ± 1.5 40.1 4- 4.4 
C3a Cug/dl) 741.9 + 327.4 397.8 + 87.5 198.0 + 26.0 
OA e x p (% of normal) 52 56 64 
OA r e a l (% of normal) 12.9 + 2.7 5.9 + 1.2 53 ± 4.8 
leukocytes 73.0 4- 13.7 32.0 + 14.1 <0.5 
(1000/mm3) 
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F I G U R E 3 C3 Splitting in serum and exudate as demonstrated by crossed immunoelectrophoresis. 
(a) Normal serum without C3 Splitting, (b) Patient serum with only trace amounts of C3 degradation 
products. (c) Exudate (35,000 leukocytes/mm3) with distinct C3 breakdown into smaller components (right 
peak), (d) Purulent Peritonitis exudate (94,000 leukocytes/mm3) with extensive Splitting of C3 complement. 
acute Peritonitis and highest in clear exudates of successful E L . The electrophoretic 
protein distribution pattern was similar to that found in serum (data not shown). 
Exudates from acute Peritonitis contained the highest leukocyte concentrations and 
also the highest levels of C3 activation products. In purulent E L exudates, both mean 
leukocyte count and C3a levels were about half of the amount found in acute 
Peritonitis. Clear E L exudates showed the lowest C3a concentrations and only few 
leukocytes. Based on the serum correlation between Opsonin concentration and 
function (Figure 2) the Opsonin levels in the exudate samples should result in an 
opsonic function of 52% of normal for acute Peritonitis, 56% of normal for purulent 
E L , and 64% of normal for clear E L . Experimentally determined opsonic activities, 
however, were much lower for acute Peritonitis (12.9% of normal) and for purulent 
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F I G U R E 4 Bacterial spectrum in acute Peritonitis and Etappenlavage. 
E L (5.9% of normal). In contrast the opsonic activity in clear exudate samples from 
the end of E L was 53% of normal, thus showing only a small reduction of opsonic 
capacity compared to the immunologically measured concentration (64% of normal). 
Obviously, a major part of the immunologically detectable Opsonins in purulent 
exudates are functionally impaired. Opsonin breakdown was examined using crossed 
immunoelectrophoresis in 6 patients' serum and exudate samples employing a C3c 
antibody. With this test, no C3 Splitting was detectable in normal serum (Figure 3). 
In Peritonitis serum, only a small amount of C3 was fragmented. In contrast, in 
purulent exudate C3 was split into fragments of lower molecular weight. The degree 
of Splitting appeared to increase with increasing leukocyte concentrations in the 
exudate. 
Cultures of the exudates revealed a wide variety of different bacteria without any 
Single species dominating. In E L , there was a pronounced contamination of the 
exudates with Staphylococcus epidermidis. Anaerobic infections were also rare in E L 
(Figure 4). Colonization with multiple bacterial species was increased in purulent E L ; 
no sterile samples were found in these patients (Figure 5). 
We quantified PMN-elastase (in complex with a,-proteinase inhibitor) and mye-
loperoxidase levels in 67 exudates. Complexed elastase in exudates from acute 
3 Spec ies 4 Spec ies 
19% 4 2 % 
Acute Per i ton i t is (n = 27 ) Pers is tent Per i toni t is (n = 21 ) 
F I G U R E 5 Multiple species infection in Peritonitis exudate. 
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T A B L E III 
Granulocyte enzymes and arproteinase inhibitor (a, PI) in Peritonitis exudates (means ± SEM) 
acute Peritonitis 
exudates (n = 23) 
purulent EL 
exudates (n = 30) 
clear E L 
exudates (n = 14) 
elastase-a, PI 58 163 ± 11 176 80 082 ± 10 380 3 139 ± 967 
feg/ml) 
myeloperoxidase 52 990 ± 6 317 52 200 ± 14 227 3 770 ± I 145 
(Mg/ml) 
a, PI (Aig/ml) 2 000 ± 159 2 010 ± 187 2 490 ± 300 
Peritonitis and purulent E L raised up to a mean concentration of 80 mg/1, i.e. 1000 
times higher than the normal plasma ränge. The highest values were found in purulent 
E L (Table III) with Single maximal values up to 160 mg/ml. Moreover we demon-
strated extremely high concentrations of myeloperoxidase reaching up to Single 
maximal values of 160 mg/1 in acute Peritonitis and purulent E L exudates. However, 
clear E L exudates contained only low concentrations of P M N L enzymes. A l l exudates 
showed essentially normal concentrations of immunologically determined total a, PI. 
Several exudate samples were examined for free elastase activity, both with a 
specific chromogenic Substrate and by adding a, PI. In some exudates, up to 70% of 
the total elastase content was found to be uninhibited, enzymatically active elastase. 
The concentration for a, PI in these exudates ranged from 990 to 3410 mg/1. Ca l -
culated on the base of molar ratio, such concentrations should be sufficient for 
complete elastase inhibition. In these patients (all with gastrointestinal Perforation), 
intraabdominal elastase levels varied within a wide ränge (Table IV). Plotting Opsonin 
levels versus opsonic activity for these Peritonitis exudates, it could be demonstrated 
that most samples lacked opsonic activity almost completely (Figure 6). A few 
exudates, however, reached almost normal opsonic activity according to the serum 
relationship. Analysis of elastase-a, PI levels revealed that these were rather clear 
exudates with only minor elastase contamination (< 10 mg/1), whereas, exudates with 
high elastase levels (> 10 mg/1) were deficient in opsonic function. 
D I S C U S S I O N 
Using the chemiluminescence assay, analysis of particle opsonization can be rather 
easily accomplished in serum and exudate. Our results confirm the key role of IgG and 
C3 in particle opsonization. In both normal and pathological sera, Opsonin con-
centration and Opsonin function was well correlated. Our results also support 
T A B L E IV 
Free and complexed elastase and a, -proteinase inhibitor (a, PI) in 4 patients' exudates after gastrointestinal 
Perforation 
a, Pl-elastase free elastase total elastase total a, PI 
complex (mg/1) (mg/1) (mg/1) (mg/1) 
Pat. 1 120.6 272.3 392.9 2250 
Pat. 2 45.7 0.5 46.2 1610 
Pat. 3 111.1 1.6 112.7 1060 
Pat. 4 54.6 73.1 127.7 990 
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F I G U R E 6 Relationship between Opsonin levels and opsonic function in Peritonitis exudate. The curve 
demonstrates the relationship obtained in patients' sera. 
previous findings that factors of the humoral defence System are diminished in the 
serum of septic patients. 2 3 , 2 4 
To date, little information has been available about intraperitoneal Opsonin con-
centrations, and no data have been published about particle opsonization in 
Peritonitis exudates. In pleural empyemas, local exhaustion of complement com-
ponents, with decreased opsonic activity, has been described.2 5'2 6 Since we could 
demonstrate a normal electrophoretic protein distribution pattern in exudates com-
pared to serum a distinct increase in peritoneal permeability in Peritonitis with easy 
passage even for large proteins can be assumed. Therefore, we conclude, that the 
reduction of several proteins in Peritonitis exudates compared with serum is due to 
consumption of these specific proteins. Immunologically-determined Opsonin levels 
were 40-50% of serum concentrations. Although this amount should be sufficient for 
opsonization, we found a marked dysfunction of particle opsonization in human 
Peritonitis exudates. This suggests that most of the Opsonins were functionally defi-
cient. Complement C3 is not only one of the main phagocytosis promoting factors but 
also the central component of the whole complement System.27 Crossed immunoelec-
trophoresis for C3 using C3c-antibodies showed an extensive destruction and break-
down of C3 in purulent exudates. The stained, C3c-containing fragments seem to be 
C3 degrading products without opsonic function. Extensive specific C3 activation is 
indicated by the high C3a concentrations and might be induced by the contamination 
of the exudates with multispecies microbes and other foreign particles. 
Additionally, C3 degradation can also proceed via a nonspecific pathway of proteo-
lytic and oxidative destruction. 2 5 , 2 6 ' 2 8 The exudate levels of P M N L enzymes exceed all 
known pathological blood concentrations even in severe septic shock. 2 9 This is prob-
344 A. BILLING et al. 
ably not only due to a very high number of activated or disintegrated leukocytes but 
also to a slower clearance of elastase-a, PI complexes from the abdominal cavity 
compared to the circulation. Despite a quantitatively sufficient immunological con-
centration of a, PI we demonstrated uninhibited elastase enzymatic activity. Since 
oxidative impairment of the inhibitory capacity of a, PI has been described in vitro9 
such damage might have occurred in the peritoneal cavity due to the release of 
myeloperoxidase or oxygen derived free radicals. The former has been demonstrated 
in great quantity in many of the exudates. 
Our results support Opsonin breakdown being an important mechanism in the 
impaired intraabdominal defence observed in Peritonitis patients. Proteolytic de-
gradation of the essential complement components seems to be due to specific 
activation of the complement cascades during contact with inflammatory Stimuli 
(microbes, cell debris etc.) as well as to unspecific breakdown by high concentrations 
of extracellularly released granulocytic proteinases. Although the activity of the latter 
enzymes is normally well regulated by a sufficient amount of extracellular Proteinase 
inhibitors, the local inhibitory function of these proteins is obviously abolished in the 
inflammatory focus. 
From a therapeutic point of view, Clearing of the focus of Peritonitis and thorough 
intraoperative rinsing of the abdominal cavity is essential. However, our results 
suggest that local Substitution of intact Opsonins and protease inhibitors may be 
beneficial. A t present, this could most easily be accomplished by intraabdominal 
application of serum or defibrinated plasma at the end of the Peritonitis Operation. 
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